Krystal Biotech Inc (KRYS)

Exchange
NASDAQ
Symbol
KRYS
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.
Country
USA

Stock price

At close: February 6, 2026

  • Open
    276.89
  • High
    277.11
  • Low
    260.03
  • Close
    272.74
  • Volume
    313,242

Financial ratios

Dec 31, 2024